Figure 6.
Figure 6. Both pE CD8+ T subsets display the same distinctive replicative history. (A) Real-time PCR quantification of TRECs was performed on sorted RA+CCR7+27+28+ (N), RA+CCR7–27+28+ (pE1), RA+CCR7–27+28– (pE2), and RA+CCR7–27–28– (E) CD8 subsets from 4 healthy individuals (< 35 years old). Asterisk indicates not detectable (sorted cell number was 105, lower quantification limit = 0.01%). (B) Telomere fluorescence analysis in sorted N, pE1, pE2, and E CD8+ T cells. The telomere fluorescence was converted to kilobase as described in “Materials and methods.” (C) Telomerase activity in cell extracts of sorted 28+DR+, 28+DR–, N, pE1, pE2, E, pE1 (28+DR+), pE2 + E (28–DR+), and EM1 (28+DR+) CD8+ T cells. As positive control, we used cell extracts of in vitro PHA-activated CD8+ T cell (act. CD8+). Data are representative of 4 healthy individuals.

Both pE CD8+ T subsets display the same distinctive replicative history. (A) Real-time PCR quantification of TRECs was performed on sorted RA+CCR7+27+28+ (N), RA+CCR727+28+ (pE1), RA+CCR727+28 (pE2), and RA+CCR72728 (E) CD8 subsets from 4 healthy individuals (< 35 years old). Asterisk indicates not detectable (sorted cell number was 105, lower quantification limit = 0.01%). (B) Telomere fluorescence analysis in sorted N, pE1, pE2, and E CD8+ T cells. The telomere fluorescence was converted to kilobase as described in “Materials and methods.” (C) Telomerase activity in cell extracts of sorted 28+DR+, 28+DR, N, pE1, pE2, E, pE1 (28+DR+), pE2 + E (28DR+), and EM1 (28+DR+) CD8+ T cells. As positive control, we used cell extracts of in vitro PHA-activated CD8+ T cell (act. CD8+). Data are representative of 4 healthy individuals.

Close Modal

or Create an Account

Close Modal
Close Modal